126 related articles for article (PubMed ID: 37877215)
21. Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort study.
Kroese TE; Christ SM; van Rossum PSN; Burger MDL; Buijs GS; Mühlematter U; Andratschke N; Ruurda JP; Hüllner M; Gutschow CA; van Hillegersberg R; Guckenberger M
Radiother Oncol; 2022 Aug; 173():269-276. PubMed ID: 35753555
[TBL] [Abstract][Full Text] [Related]
22. Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.
Ho VK; Gijtenbeek JM; Brandsma D; Beerepoot LV; Sonke GS; van der Heiden-van der Loo M
Eur J Cancer; 2015 Nov; 51(17):2508-16. PubMed ID: 26277099
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site.
Xu P; Wang J; Abudurexiti M; Jin S; Wu J; Shen Y; Ye D
Front Oncol; 2019; 9():1495. PubMed ID: 31998648
[No Abstract] [Full Text] [Related]
24. Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer.
Maroto P; García Del Muro X; Valverde C; Pinto A; Sanchez A; Guma J; Alonso T; Martínez Del Prado P; Vazquez S; Mellado B; Aparicio J; Fernandez-Aramburo A; Girones R; Terrasa J;
Urol Oncol; 2021 Feb; 39(2):135.e17-135.e23. PubMed ID: 33189529
[TBL] [Abstract][Full Text] [Related]
25. The survival and prognostic factors of primary testicular lymphoma: two-decade single-center experience.
Ma RZ; Tian L; Tao LY; He HY; Li M; Lu M; Ma LL; Jiang H; Lu J
Asian J Androl; 2018; 20(6):615-620. PubMed ID: 30246707
[TBL] [Abstract][Full Text] [Related]
26. Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study.
Kroese TE; Takahashi Y; Lordick F; van Rossum PSN; Ruurda JP; Lagarde SM; van Hillegersberg R; Verhoeven RHA; van Laarhoven HWM
Eur J Cancer; 2023 Jan; 179():65-75. PubMed ID: 36509000
[TBL] [Abstract][Full Text] [Related]
27. Site of extranodal metastasis impacts survival in patients with testicular germ cell tumors.
Patel HD; Singla N; Ghandour RA; Freifeld Y; Cheaib JG; Woldu SL; Pierorazio PM; Bagrodia A
Cancer; 2019 Nov; 125(22):3947-3952. PubMed ID: 31355922
[TBL] [Abstract][Full Text] [Related]
28. Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population.
van de Ven SEM; Falger JM; Verhoeven RHA; Baatenburg de Jong RJ; Spaander MCW; Bruno MJ; Koch AD
United European Gastroenterol J; 2021 May; 9(4):497-506. PubMed ID: 33270530
[TBL] [Abstract][Full Text] [Related]
29. Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma.
Rose JS; Serna DS; Martin LK; Li X; Weatherby LM; Abdel-Misih S; Zhao W; Bekaii-Saab T
Cancer; 2012 Dec; 118(24):6243-52. PubMed ID: 22674181
[TBL] [Abstract][Full Text] [Related]
30. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.
Schaapveld M; van den Belt-Dusebout AW; Gietema JA; de Wit R; Horenblas S; Witjes JA; Hoekstra HJ; Kiemeney LA; Louwman WJ; Ouwens GM; Aleman BM; van Leeuwen FE
Br J Cancer; 2012 Oct; 107(9):1637-43. PubMed ID: 23059747
[TBL] [Abstract][Full Text] [Related]
31. Minimal Increase in Survival Throughout the Years in Patients with Soft Tissue Sarcoma with Synchronous Metastases: Results of a Population-Based Study.
Vos M; Ho VKY; Oosten AW; Verhoef C; Sleijfer S
Oncologist; 2019 Jul; 24(7):e526-e535. PubMed ID: 30190301
[TBL] [Abstract][Full Text] [Related]
32. Modeling growth kinetics and statistical distribution of oligometastases.
Withers HR; Lee SP
Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
[TBL] [Abstract][Full Text] [Related]
33. Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.
Hong JC; Ayala-Peacock DN; Lee J; Blackstock AW; Okunieff P; Sung MW; Weichselbaum RR; Kao J; Urbanic JJ; Milano MT; Chmura SJ; Salama JK
PLoS One; 2018; 13(4):e0195149. PubMed ID: 29649281
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma.
Choi SY; Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
Clin Genitourin Cancer; 2017 Dec; 15(6):717-723. PubMed ID: 28552571
[TBL] [Abstract][Full Text] [Related]
35. Metastasis in the gallbladder: does literature reflect reality?
de Bitter TJJ; Trapman DM; Simmer F; Hugen N; de Savornin Lohman EAJ; de Reuver PR; Verheij J; Nagtegaal ID; van der Post RS
Virchows Arch; 2022 Jun; 480(6):1201-1209. PubMed ID: 35357569
[TBL] [Abstract][Full Text] [Related]
36. Bilateral testicular tumours: prevalence and clinical implications.
Bokemeyer C; Schmoll HJ; Schöffski P; Harstrick A; Bading M; Poliwoda H
Eur J Cancer; 1993; 29A(6):874-6. PubMed ID: 8387319
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer ovarian metastases.
Thornblade LW; Han E; Fong Y
Int J Gynecol Cancer; 2021 Aug; 31(8):1137-1144. PubMed ID: 34083378
[TBL] [Abstract][Full Text] [Related]
38. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
39. Does surgery benefit patients with oligometastatic or metastatic prostate cancer? - A retrospective cohort study and meta-analysis.
Si S; Zheng B; Wang Z; Niu Z
Prostate; 2021 Aug; 81(11):736-744. PubMed ID: 34056739
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer.
Rogowski P; Trapp C; von Bestenbostel R; Schmidt-Hegemann NS; Shi R; Ilhan H; Kretschmer A; Stief C; Ganswindt U; Belka C; Li M
Radiat Oncol; 2021 Jun; 16(1):125. PubMed ID: 34193194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
